Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The issue included new and updated reviews on various health interventions, with significant findings on weight loss, psychological therapies, cancer treatment, and more.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Ashwagandha root improved symptoms of nonclassic 11-hydroxylase deficiency in an elderly woman.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

People with HIV and low T cell counts have more hair and scalp problems.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Zidovudine may cause hair loss in advanced-stage HIV patients.

The book is a comprehensive and current guide on hair disorders, with minor flaws.

The issue discussed China's research contributions, systematic review improvements, and featured various medical studies and trials.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

Hormonal imbalances are a key cause of missed menstrual periods in women.